(Q43826454)

27 November 2017

title

Clozapine-associated diabetes (English)

1 reference

27 November 2017

Koller E

1

1 reference

27 November 2017

Schneider B

series ordinal

2

1 reference

27 November 2017

Bennett K

series ordinal

3

1 reference

27 November 2017

Dubitsky G

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

American Journal of Medicine

27 November 2017

published in

1 reference

27 November 2017

volume

111

1 reference

27 November 2017

issue

9

1 reference

27 November 2017

page(s)

716-723

1 reference

Medical complications of new antipsychotic drugs

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Diabetic ketoacidosis and clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Diabetic ketoacidosis associated with clozapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Lethal interaction of clozapine and buspirone?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Insulin-resistant hyperglycemia induced by clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Severe hyperglycemia associated with high doses of clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Ketoacidosis as a side-effect of clozapine: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Diabetic ketoacidosis associated with clozapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Schizophrenia and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Diabetic ketoacidosis from clozapine and lithium cotreatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Clozapine monotherapy and ketoacidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Clozapine and associated diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Diabetes as a result of atypical anti-psychotic drugs--a report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Clozapine-induced diabetic ketoacidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Hepatitis, hyperglycemia, pleural effusion, eosinophilia, hematuria and proteinuria occurring early in clozapine treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Diabetes mellitus associated with clozapine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Novel antipsychotics and new onset diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Hyperglycemia, hyperlipemia, and periodic paralysis: a case report of new side effects of clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Attitudinal survey of voluntary reporting of adverse drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Adverse events after protamine administration in patients undergoing cardiopulmonary bypass: risks and predictors of under-reporting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Reporting of adverse drug reactions by hospital doctors and the response to intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Clozapine and body mass change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Neuroleptic malignant syndrome and diabetic keto-acidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Hyperglycemia associated with olanzapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Diabetic ketoacidosis with olanzapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Hyperglycemia and olanzapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Prevalence and correlates of diabetes in national schizophrenia samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Diabetes mellitus in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Autoimmune diseases in the pedigrees of schizophrenic and control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

Lactic acidosis and fatal myocardial failure due to clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901000-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(01)01000-2

1 reference

27 November 2017

1 reference